Skip to main content
. Author manuscript; available in PMC: 2022 Apr 15.
Published in final edited form as: Cancer. 2020 Dec 11:10.1002/cncr.33370. doi: 10.1002/cncr.33370

TABLE 1.

Demographic and Clinical Characteristics of Patients With Oropharyngeal Cancer Who Survived at Least 5 Years After Diagnosis

Characteristic No. of Patients (%)

Age at diagnosis, median (IQR), y 60 (55–68)
Radiation dose, median (IQR), Gy 70 (66–70.5)
Sex
 Male 1407 (82.8)
 Female 292 (17.2)
Period of diagnosis
 1980–1989 133 (7.8)
 1990–1999 311 (18.3)
 2000–2013 1255 (73.9)
Smoking status
 Never 744 (44.2)
 Former 571 (33.9)
 Current 370 (22.0)
 Missing 14
Smoking, pack-years
 ≤10 956 (58.4)
 >10 680 (41.6)
 Missing 63
Site
 Tonsil 773 (45.5)
 Base of tongue 821 (48.3)
 Other 105 (6.2)
HPV status
 Negative 48 (10.1)
 Positive 429 (89.9)
 Missing 1222
T category
 T1 523 (30.8)
 T2 639 (37.6)
 T3 353 (20.8)
 T4 183 (10.8)
 Missing 1
N category (AJCC 7th ed.)
 N0 218 (12.9)
 N1 330 (19.4)
 N2 1045 (61.5)
 N3 105 (6.2)
 Missing 1
Neck dissection
 No 1306 (76.9)
 Yes 393 (23.1)
IMRT
 No 621 (36.6)
 Yes 1078 (63.4)
Fractionation
 Conventional 1164 (68.7)
 Concomitant boost 456 (26.9)
 Other 75 (4.4)
 Missing 4
Radiation dose, Gy
 >70 440 (26.0)
 >66–70 622 (36.7)
 ≤66 633 (37.3)
 Missing 4
Chemotherapy
 None 726 (42.7)
 Adjuvant only 266 (15.7)
 Concurrent only 485 (28.5)
 Both 222 (13.1)
Recurrencea
 None 1614 (95.0)
 Local 53 (3.1)
 Regional 9 (0.5)
 Distant 35 (2.1)
Second primary tumor
 No 1408 (84.5)
 Yes 258 (15.5)
 Missing 33

Abbreviations: AJCC, American Joint Committee on Cancer; HPV, human papillomavirus; IMRT, intensity-modulated radiation therapy; IQR, interquartile range.

a

Groups not mutually exclusive.